Erratum: Palivizumab prophylaxis in preterm infants and subsequent recurrent wheezing. Six-year follow-up study (American Journal of Respiratory and Critical Care Medicine (2017) 196 (29-38) DOI: 10.1164/rccm.201609-1812OC);Palivizumab prophylaxis in preterm infants and subsequent recurrent wheezing: Six-year follow-up study

American Journal of Respiratory and Critical Care Medicine

Volumn 196, Issue 1, 2017, Pages 29-38

  Mochizuki, Hiroyuki ^a   Kusuda, Satoshi ^b   Okada, Kenji ^c   Yoshihara, Shigemi ^d   Furuya, Hiroyuki ^a   Simões, Eric A F ^e   Asanuma, Hideomi ^f   Yoshida, Hiroshi ^g   Katayose, Masahiko ^h   Imamura, Takashi ⁱ   Suzumura, Hiroshi ^d   Honma, Youko ^j   Maruyama, Kenichi ^k   Ohki, Yasushi ^l   Ozasa, Koji ^m   Nariai, Akiyoshi ⁿ   Uchiyama, Atsushi ^b   Uryu, Hideko ^o   Hosono, Shigeharu ^p   Kondo, Masatoshi ^q   Kawase, Yasuharu ^r   Ikeda, Kazunari ^s,t   Naito, Atsushi ^u   Minami, Yuki ^v   Nakamura, Tomohiko ^w   Baba, Atsushi ^x   Nagayama, Yoshihisa ^y   Kaneda, Hisashi ^z   Ohki, Shigeru ^aa   Shirai, Masami ^ab   Henmi, Yuto ^ac   Suzuki, Chizuko ^ad   Ieda, Kuniko ^ae   Tanaka, Taihei ^af   Kono, Yoshinori ^ag   Nisizawa, Kashiro ^ah   Niwa, Fusako ^ai   Ito, Hisato ^aj   Tokunaga, Yasuyuki ^ak   Takada, Yoshinobu ^al   Nishikawa, Yoshihide ^am   Nagata, Ikuo ^an   Kajino, Yasuhisa ^ao   Watabe, Shinichi ^ap   Yoshio, Hiroyuki ^aq   Takahashi, Nobumasa ^ar   Sasaki, Nobutaka ^as   Hayashidani, Michiko ^at   Tateishi, Hiroshi ^au   Matsushita, Kenji ^av   Nakamura, Masatoshi ^aw   Nakayama, Hideki ^ax   Yamamoto, Go ^ay   Kanemitsu, Noriaki ^az   Takayanagi, Toshimitsu ^ba   Sato, Ayumi ^bb   Ibara, Satoshi ^bc   more..

^a TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^c FUKUOKA DENTAL COLLEGE   (Japan)

^d DOKKYO MEDICAL UNIVERSITY   (Japan)

^e UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^f Tomakomai City Hospital   (Japan)

^g Tsuruoka Municipal Shonai Hospital   (Japan)

^h Public Soma General Hospital   (Japan)

ⁱ FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^j JICHI MEDICAL UNIVERSITY   (Japan)

^k Gunma Children's Medical Center   (Japan)

^l GUNMA UNIVERSITY HOSPITAL   (Japan)

^m SAISEIKAI YOKOHAMASHI NANBU HOSPITAL   (Japan)

ⁿ Yokohama Minami Kyosai Hospital   (Japan)

^o NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^p NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^q TOKYO METROPOLITAN CHILDREN'S MEDICAL CENTER   (Japan)

^r TOHO UNIVERSITY OMORI MEDICAL CENTER   (Japan)

^s KEIO UNIVERSITY HOSPITAL   (Japan)

^t Sho Hospital   (Japan)

^u Yamanashi Prefectural Central Hospital   (Japan)

^v NAGANO RED CROSS HOSPITAL   (Japan)

^w NAGANO CHILDREN'S HOSPITAL   (Japan)

^x SHINSHU UNIVERSITY HOSPITAL   (Japan)

^y NIIGATA CITY GENERAL HOSPITAL   (Japan)

^z Toyama City Hospital   (Japan)

^aa SEIREI HAMAMATSU GENERAL HOSPITAL   (Japan)

^ab Iwata City Hospital   (Japan)

^ac Aichi Prefectural Colony Central Hospital   (Japan)

^ad JAPANESE RED CROSS NAGOYA FIRST HOSPITAL   (Japan)

^ae TOSEI GENERAL HOSPITAL   (Japan)

^af NAGOYA DAINI RED CROSS HOSPITAL   (Japan)

^ag Gifu Prefectural Central Medical Center   (Japan)

^ah Department of Dermatology Omihachiman Community Medical Center   (Japan)

^ai KYOTO UNIVERSITY HOSPITAL   (Japan)

^aj KYOTO SECOND RED CROSS HOSPITAL   (Japan)

^ak TOYONAKA MUNICIPAL HOSPITAL   (Japan)

^al OSAKA KOSEI NENKIN HOSPITAL   (Japan)

^am Aizenbashi Hospital   (Japan)

^an TOTTORI UNIVERSITY HOSPITAL   (Japan)

^ao Masuda Red Cross Hospital   (Japan)

^ap KURASHIKI CENTRAL HOSPITAL   (Japan)

^aq National Hospital Organization Oakayama Medical Center   (Japan)

^ar NATIONAL HOSPITAL ORGANIZATION FUKUYAMA MEDICAL CENTER   (Japan)

^as JA Onomichi General Hospital   (Japan)

^at HIROSHIMA CITY HOSPITAL   (Japan)

^au Tokuyama Central Hospital   (Japan)

^av KOCHI MEDICAL SCHOOL HOSPITAL   (Japan)

^aw FUKUOKA UNIVERSITY HOSPITAL   (Japan)

^ax FUKUOKA CHILDREN S HOSPITAL   (Japan)

^ay Department of Surgery Fukuoka Tokusyukai Medical Center   (Japan)

^az National Hospital Organization Kokura National Hospital   (Japan)

^ba National Saga Hospital   (Japan)

^bb KUMAMOTO CITY HOSPITAL   (Japan)

^bc Kagoshima City Hospital   (Japan)

more..

Author keywords

Asthma; Monoclonal antibody; Palivizumab; Respiratory infectious diseases; Respiratory syncytial virus

Indexed keywords

PALIVIZUMAB; ANTIVIRUS AGENT;

ALLERGIC ASTHMA; ARTICLE; BLOOD EXAMINATION; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FOLLOW UP; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; OUTPATIENT; PREMATURITY; PRESCHOOL CHILD; PRIORITY JOURNAL; PROPHYLAXIS; PROSPECTIVE STUDY; RECURRENT DISEASE; RESPIRATORY SYNCYTIAL VIRUS INFECTION; WHEEZING; ABNORMAL RESPIRATORY SOUND; ASTHMA; CASE CONTROL STUDY; CLINICAL TRIAL; DRUG EFFECTS; HUMAN RESPIRATORY SYNCYTIAL VIRUS; INFANT; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; TREATMENT OUTCOME;

ANTIVIRAL AGENTS; ASTHMA; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; INFANT, PREMATURE; MALE; PALIVIZUMAB; PROSPECTIVE STUDIES; RECURRENCE; RESPIRATORY SOUNDS; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUSES; TREATMENT OUTCOME;

EID: 85021139678     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.1975Erratum     Document Type: Erratum

References (43)

1. Sigurs N, Bjarnason R, Sigurbergsson F, Kjellman B. Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7. Am J Respir Crit Care Med 2000;161: 1501-1507.
2. Sigurs N, Aljassim F, Kjellman B, Robinson PD, Sigurbergsson F, Bjarnason R, Gustafsson PM. Asthma and allergy patterns over 18 years after severe RSV bronchiolitis in the first year of life. Thorax 2010;65:1045-1052.
3. Sigurs N, Gustafsson PM, Bjarnason R, Lundberg F, Schmidt S, Sigurbergsson F, Kjellman B. Severe respiratory syncytial virus bronchiolitis in infancy and asthma and allergy at age 13. Am J Respir Crit Care Med 2005;171:137-141.
4. Stein RT, Sherrill D, Morgan WJ, Holberg CJ, Halonen M, Taussig LM, Wright AL, Martinez FD. Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years. Lancet 1999;354:541-545.
5. Bont L, Steijn M, van Aalderen WM, Kimpen JL. Impact of wheezing after respiratory syncytial virus infection on health-related quality of life. Pediatr Infect Dis J 2004;23:414-417.
6. Henderson J, Hilliard TN, Sherriff A, Stalker D, Al Shammari N, Thomas HM. Hospitalization for RSV bronchiolitis before 12 months of age and subsequent asthma, atopy and wheeze: a longitudinal birth cohort study. Pediatr Allergy Immunol 2005;16:386-392.
7. Román M, Calhoun WJ, Hinton KL, Avendaño LF, Simon V, Escobar AM, Gaggero A, Díaz PV. Respiratory syncytial virus infection in infants is associated with predominant Th-2-like response. Am J Respir Crit Care Med 1997;156:190-195.
8. Johnson S, Oliver C, Prince GA, Hemming VG, Pfarr DS, Wang SC, Dormitzer M, O'Grady J, Koenig S, Tamura JK, et al. Development of a humanized monoclonal antibody (MEDI-493) with potent in vitro and in vivo activity against respiratory syncytial virus. J Infect Dis 1997; 176:1215-1224.
9. IMpact-RSV Study Group. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. Pediatrics 1998;102:531-537.
10. Simoes EA, Groothuis JR, Carbonell-Estrany X, Rieger CH, Mitchell I, Fredrick LM, Kimpen JL. Palivizumab prophylaxis, respiratory syncytial virus, and subsequent recurrent wheezing. J Pediatr 2007; 151:34-42, 42.e1.
11. Simões EA, Carbonell-Estrany X, Rieger CH, Mitchell I, Fredrick L, Groothuis JR; Palivizumab Long-Term Respiratory Outcomes Study Group. The effect of respiratory syncytial virus on subsequent recurrent wheezing in atopic and nonatopic children. J Allergy Clin Immunol 2010;126:256-262.
12. Yoshihara S, Kusuda S, Mochizuki H, Okada K, Nishima S, Simões EA; C-CREW Investigators. Effect of palivizumab prophylaxis on subsequent recurrent wheezing in preterm infants. Pediatrics 2013; 132:811-818.
13. Henderson J, Granell R, Heron J, Sherriff A, Simpson A, Woodcock A, Strachan DP, Shaheen SO, Sterne JA. Associations of wheezing phenotypes in the first 6 years of life with atopy, lung function and airway responsiveness in mid-childhood. Thorax 2008;63: 974-980.
14. Savenije OE, Granell R, Caudri D, Koppelman GH, Smit HA, Wijga A, de Jongste JC, Brunekreef B, Sterne JA, Postma DS, et al. Comparison of childhood wheezing phenotypes in 2 birth cohorts: ALSPAC and PIAMA. J Allergy Clin Immunol 2011;127:1505-1512.e14.
15. Savenije OE, Mahachie John JM, Granell R, Kerkhof M, Dijk FN, de Jongste JC, Smit HA, Brunekreef B, Postma DS, Van Steen K, et al. Association of IL33-IL-1 receptor-like 1 (IL1RL1) pathway polymorphisms with wheezing phenotypes and asthma in childhood. J Allergy Clin Immunol 2014;134:170-177.
16. Reddel HK, Bateman ED, Becker A, Boulet LP, Cruz AA, Drazen JM, Haahtela T, Hurd SS, Inoue H, de Jongste JC, et al. A summary of the new GINA strategy: a roadmap to asthma control. Eur Respir J 2015; 46:622-639.
17. Martinez FD, Wright AL, Taussig LM, Holberg CJ, Halonen M, Morgan WJ; The Group Health Medical Associates. Asthma and wheezing in the first six years of life. N Engl J Med 1995;332:133-138.
18. Spycher BD, Silverman M, Brooke AM, Minder CE, Kuehni CE. Distinguishing phenotypes of childhood wheeze and cough using latent class analysis. Eur Respir J 2008;31:974-981.
19. Schultz A, Devadason SG, Savenije OE, Sly PD, Le Souëf PN, Brand PL. The transient value of classifying preschool wheeze into episodic viral wheeze and multiple trigger wheeze. Acta Paediatr 2010;99:56-60.
20. Jafri HS, Chavez-Bueno S, Mejias A, Gomez AM, Rios AM, Nassi SS, Yusuf M, Kapur P, Hardy RD, Hatfield J, et al. Respiratory syncytial virus induces pneumonia, cytokine response, airway obstruction, and chronic inflammatory infiltrates associated with long-term airway hyperresponsiveness in mice. J Infect Dis 2004; 189:1856-1865.
21. Lemanske RF Jr. The childhood origins of asthma (COAST) study. Pediatr Allergy Immunol 2002;13:38-43.
22. Caballero MT, Serra ME, Acosta PL, Marzec J, Gibbons L, Salim M, Rodriguez A, Reynaldi A, Garcia A, Bado D, et al. TLR4 genotype and environmental LPS mediate RSV bronchiolitis through Th2 polarization. J Clin Invest 2015;125:571-582.
23. Hall CB, Simoes EA, Anderson LJ. Clinical and epidemiologic features of respiratory syncytial virus. Curr Top Microbiol Immunol 2013;372: 39-57.
24. Bertrand JM, Riley SP, Popkin J, Coates AL. The long-term pulmonary sequelae of prematurity: the role of familial airway hyperreactivity and the respiratory distress syndrome. N Engl J Med 1985;312: 742-745.
25. Been JV, Lugtenberg MJ, Smets E, van Schayck CP, Kramer BW, Mommers M, Sheikh A. Preterm birth and childhood wheezing disorders: a systematic review and meta-analysis. PLoS Med 2014; 11:e1001596.
26. He H, Butz A, Keet CA, Minkovitz CS, Hong X, Caruso DM, Pearson C, Cohen RT, Wills-Karp M, Zuckerman BS, et al. Preterm birth with childhood asthma: the role of degree of prematurity and asthma definitions. Am J Respir Crit Care Med 2015;192:520-523.
27. Blanken MO, Rovers MM, Molenaar JM, Winkler-Seinstra PL, Meijer A, Kimpen JL, Bont L; Dutch RSV Neonatal Network. Respiratory syncytial virus and recurrent wheeze in healthy preterm infants. N Engl J Med 2013;368:1791-1799.
28. O'Brien KL, Chandran A, Weatherholtz R, Jafri HS, Griffin MP, Bellamy T, Millar EV, Jensen KM, Harris BS, Reid R, et al.; Respiratory Syncytial Virus (RSV) Prevention study group. Efficacy of motavizumab for the prevention of respiratory syncytial virus disease in healthy Native American infants: a phase 3 randomised double-blind placebo-controlled trial. Lancet Infect Dis 2015;15: 1398-1408.
29. Pullan CR, Hey EN. Wheezing, asthma, and pulmonary dysfunction 10 years after infection with respiratory syncytial virus in infancy. Br Med J (Clin Res Ed) 1982;284:1665-1669.
30. Brand PL, Baraldi E, Bisgaard H, Boner AL, Castro-Rodriguez JA, Custovic A, de Blic J, de Jongste JC, Eber E, Everard ML, et al. Definition, assessment and treatment of wheezing disorders in preschool children: an evidence-based approach. Eur Respir J 2008;32:1096-1110.
31. Stensballe LG, Ravn H, Kristensen K, Agerskov K, Meakins T, Aaby P, Simões EA. Respiratory syncytial virus neutralizing antibodies in cord blood, respiratory syncytial virus hospitalization, and recurrent wheeze. J Allergy Clin Immunol 2009;123:398-403.
32. Kaneko M, Watanabe J, Ueno E, Hida M, Sone T. Risk factors for severe respiratory syncytial virus-associated lower respiratory tract infection in children. Pediatr Int 2001;43:489-492.
33. Caliş kan M, Bochkov YA, Kreiner-Møller E, Bønnelykke K, Stein MM, Du G, Bisgaard H, Jackson DJ, Gern JE, Lemanske RF Jr, et al. Rhinovirus wheezing illness and genetic risk of childhood-onset asthma. N Engl J Med 2013;368:1398-1407.
34. Calderón MA, Linneberg A, Kleine-Tebbe J, De Blay F, Hernandez Fernandez de Rojas D, Virchow JC, Demoly P. Respiratory allergy caused by house dust mites: what do we really know? J Allergy Clin Immunol 2015;136:38-48.
35. Ulrik CS, Backer V. Markers of impaired growth of pulmonary function in children and adolescents. Am J Respir Crit Care Med 1999;160:40-44.
36. Minami T, Fukutomi Y, Lidholm J, Yasueda H, Saito A, Sekiya K, Tsuburai T, Maeda Y, Mori A, Taniguchi M, et al. IgE Abs to Der p 1 and Der p 2 as diagnostic markers of house dust mite allergy as defined by a bronchoprovocation test. Allergol Int 2015;64:90-95.
37. Tovey ER, Almqvist C, Li Q, Crisafulli D, Marks GB. Nonlinear relationship of mite allergen exposure to mite sensitization and asthma in a birth cohort. J Allergy Clin Immunol 2008;122:114-118, 118.e1-5.
38. Celedón JC, Milton DK, Ramsey CD, Litonjua AA, Ryan L, Platts-Mills TA, Gold DR. Exposure to dust mite allergen and endotoxin in early life and asthma and atopy in childhood. J Allergy Clin Immunol 2007; 120:144-149.
39. Rhodes HL, Thomas P, Sporik R, Holgate ST, Cogswell JJ. A birth cohort study of subjects at risk of atopy: twenty-two-year follow-up of wheeze and atopic status. Am J Respir Crit Care Med 2002;165: 176-180.
40. Oddy WH, de Klerk NH, Sly PD, Holt PG. The effects of respiratory infections, atopy, and breastfeeding on childhood asthma. Eur Respir J 2002;19:899-905.
41. Illi S, von Mutius E, Lau S, Niggemann B, Grüber C, Wahn U; Multicentre Allergy Study (MAS) group. Perennial allergen sensitisation early in life and chronic asthma in children: a birth cohort study. Lancet 2006;368:763-770.
42. Kusel MM, de Klerk NH, Kebadze T, Vohma V, Holt PG, Johnston SL, Sly PD. Early-life respiratory viral infections, atopic sensitization, and risk of subsequent development of persistent asthma. J Allergy Clin Immunol 2007;119:1105-1110.
43. Sly PD, Boner AL, Björksten B, Bush A, Custovic A, Eigenmann PA, Gern JE, Gerritsen J, Hamelmann E, Helms PJ, et al. Early identification of atopy in the prediction of persistent asthma in children. Lancet 2008; 372:1100-1106.